Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Nebraska
Cedars-Sinai Medical Center
M.D. Anderson Cancer Center
University of Pennsylvania
University College, London
Mayo Clinic
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
City of Hope Medical Center
University of Florida
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of Florida
Washington University School of Medicine
University of California, Davis
University of Florida
University of Florida
M.D. Anderson Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Universität Münster
Case Comprehensive Cancer Center
Northwestern University
Case Comprehensive Cancer Center
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
University of California, San Francisco
Washington University School of Medicine
City of Hope Medical Center
Massachusetts General Hospital
University of Cincinnati
Baylor College of Medicine
CHA University
University of Virginia
St. Jude Children's Research Hospital
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Augusta University
Istituto Oncologico Veneto IRCCS
Stanford University
Northwestern University
University of Florida
Henry Ford Health System
University of Pennsylvania
University of Oklahoma
University of Iowa